Erin Griffith

ImClone co-founder Sam Waksal is out of jail and back in the game, with a new startup called Kadmon Pharmaceuticals. Kadmon began seeking investors in February, declaring plans to raise $50 million for a biotech roll-up platform. But the company seems to be shooting for its hard cap of $175 million, with investments from a range […]

Millennium Technology Ventures, a New-York based venture capital firm, is roughly a week away from holding an oversubscribed final close on its third fund. The firm launched with a $200 million target and $250 million hard cap, but has gathered at least $275 million in commitments, according to two sources familiar with the situation. The […]

Landmark Partners has closed its fourteenth private equity secondary fund with $1.93 billion in commitments, a source familiar with the situation said. The fund had a target of $2 billion. Landmark had planned a final close for the first quarter of this year and made it in just under the buzzer, officially closing the fund […]

Canada's biggest pension fund manager, Caisse de depot et placement du Quebec, said on Thursday its assets under management had recovered nearly 10 percent of their value in 2009, but were still below pre-crisis levels.

DAG Ventures has raised exactly $499.7 million for its fourth venture capital fund, according to SEC filings. The firm, based in Palo Alto, Calif., sought to raise $500 million for DAG Ventures III LP. That total does not include the general partner commitment. The fund is broken into two separate vehicles, one $47.75 million vehicle […]

Florida-based H.I.G. Ventures is in the market with a new venture capital fund focused exclusively on life sciences companies. The firm had allocated around half of its $300 million second fund to life sciences investing, according to managing director Aaron Davidson, but now feels that the strategy deserves a dedicated vehicle. The fund will focus primarily on companies developing therapeutic drugs or medical devices across sectors and stages, Davidson said. Specifically, “capital efficient businesses with large market opportunities in underserved geographies, and products with shorter development.”

CalPERS has just released a ton of docs related to placement agents used by their general partners. We're uploading them below- There are literally hundreds. Help us read through them for interesting items. Placement agent disclosure release Placement agent compensation We're posting the second half below; read the first half here.

Flywheel Ventures is seeking $35 million for its second venture capital fund, according to a regulatory filing. The Sante Fe-based firm invests in seed and early-stage information technology and physical sciences companies in the Southwest/Rockies region. Recent backings include Lingotek, a Salt Lake City-based developer of collaborative translation technology. In January, the firm gained an […]

Aquantia, a developer of silicon products for high-speed connectivity, has completed a Series D financing of $35 million immediately with up to $44 million over time. New Enterprise Associates (NEA) led the round, with participation from Aquantia’s existing investors including Lightspeed Venture Partners, Greylock Partners, Pinnacle Ventures, and Venture Tech Alliance.

Back in June we reported news of a new venture firm called Founder Collective, which had gathered around $30 million in commitments. Last week the firm made it official, debuting a web site and describing its philosophy on Partner Chris Dixon's web site. Founder Collective is quite literally just that. A collective of founders, looking to invest in seed stage companies. The firm calls it "peer-to-peer" investing. According to Managing Partner Eric Paley, the firm has closed the fund with $40 million in commitments. The capital comes from around 20 investors, an even mix of entrepreneurs, family offices, and institutional funds of funds, he said. Founder Collective used its partners' personal investment track records as a selling point. In the last six years, they invested more than $20m in 31 companies, yielding an IRR of greater than 75%, the majority of which is realized. The New York and Cambridge-based firm has already invested 10% of its fund in around 10 seed stage investments, after looking at "well into the 100s" of companies, Paley said. "The demand for this type of capital is extremely high," he said.